Cello Health Competitors, Revenue, Alternatives and Pricing

Claim your profile


Total Funding:N/A
Lead Investor(s):N/A

Industry Ranking

Estimated Revenue & Financials

  • Cello Health's estimated annual revenue is currently $108.1M per year.
  • Cello Health's estimated revenue per employee is $201,000

Employee Data

  • Cello Health has 538 Employees.
  • Cello Health grew their employee count by -1% last year.
  • Cello Health currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
Missing a competitor? Contribute!?

Cello Health delivers cutting-edge professional medical and marketing services to the global pharmaceutical, biotechnology and health sectors. Cello Health consists of three distinct capabilities to deliver a fusion of expertise to unlock the potential of organisations, brands and assets: Cello Health Insight: global marketing research and customer insight Cello Health Consulting: strategic consultancy Cello Health Communications: evidence and engagement This unique structure allows us to look at complex market challenges through multiple lenses. Enabling us to help healthcare businesses unlock the potential of their assets, brands and organisations in a changing and challenging environment. The formation of Cello Health reflects industry pressure to optimise the potential of molecular assets and demonstrate value, recognises the loss of blockbusters, and the subsequent impact on available resources to bring brands to market. The Cello Health structure gives us a broader view of commercial and clinical success, and enables us to provide a greater depth and breadth of services to help support your critical decision making. To find out more about Cello Health, please visit the products/services page or visit us at www.cellohealth.com



Number of Employees


Revenue (est)


Current Jobs


Employee Growth %


Total Funding







Cello Health News

09/03/2019 - Cello Health (LON:CLL) Share Price Passes Below 200 Day Moving Average of $125.77

Cello Health PLC (LON:CLL) shares crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving ...

09/08/2019 - Cello Health Acquires ISS

NEW YORK, Aug. 19, 2019 /PRNewswire/ -- Cello Health has announced further expansion in the United States with the acquisition of New ...

09/03/2019 - Cello Health expanding organically in Europe and the US

“2018 marked an important moment in Cello's development as we changed our name to Cello Health PLC to reflect our ongoing strategic focus ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing

Cello Health Acquisitions

DateCompany NameAmountNotesReference
2017-07-19Cello Health Advantage Inc.Article